<DOC>
	<DOC>NCT00313300</DOC>
	<brief_summary>The purpose of this clinical research study is to determine whether apixaban will be safe in people who have recently had unstable angina or a heart attack.</brief_summary>
	<brief_title>Safety Study of Apixaban in Recent Acute Coronary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>Key Recent (&lt; = 7 days) Acute Coronary Syndrome (ACS). Clinically stable on optimal treatment Key High bleeding risk. Ongoing anticoagulant use. Need for chronic (&gt;3 months) daily nonsteroidal antiinflammatory drug (NSAID) or chronic high dose acetylsalicylic acid (ASA) use (&gt;325 mg/day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>